PCSK9 Inhibitors in a Statin-Intolerant Transgender Man With Heterozygous Familial Hypercholesterolemia: A Case Report

In female-to-male transgender individuals, testosterone is used to induce masculinization. Sex steroid therapy may increase circulating triglyceride and low-density lipoprotein cholesterol (LDL-C) levels and may decrease high-density lipoprotein cholesterol (HDL-C) levels, resulting in a more athero...

Descripción completa

Detalles Bibliográficos
Autores principales: Pirazzi, Carlo, Tavaglione, Federica, Tivesten, Åsa, Romeo, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6665951/
https://www.ncbi.nlm.nih.gov/pubmed/31380502
http://dx.doi.org/10.1210/js.2019-00070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6665951/
https://www.ncbi.nlm.nih.gov/pubmed/31380502
http://dx.doi.org/10.1210/js.2019-00070

Ejemplares similares